Drugplain

Twyneo 30 mg/g

Benzoyl Peroxide and Tretinoin · CREAM · Mayne Pharma Commercial LLC

No Recall HistoryCurrently in Shortage
Plain English

Twyneo is a cream containing benzoyl peroxide and tretinoin at 30 mg/g, taken topical. Manufactured by Mayne Pharma Commercial LLC.

Key Facts

Brand Name
Twyneo
Generic Name
Benzoyl Peroxide and Tretinoin
NDC Code (Product)
51862-771
Manufacturer
Mayne Pharma Commercial LLC
Strength
30 mg/g
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Application #
NDA214902
Drug Class
Retinoid [EPC]
Marketing Start
08/01/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

skin burning sensation7 reports
acne6 reports
erythema6 reports
dry skin5 reports
inappropriate schedule of product administration5 reports
intentional product misuse4 reports
pain of skin4 reports
poor quality product administered4 reports
pruritus4 reports
drug ineffective3 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

1 INDICATIONS AND USAGE TWYNEO is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. TWYNEO is a combination tretinoin, a retinoid, and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. ( 1 )

Dosage & Administration

2 DOSAGE AND ADMINISTRATION Apply a thin layer of TWYNEO to the affected areas once daily on clean and dry skin. Avoid contact with the eyes, lips, paranasal creases, and mucous membranes. Wash hands after application. TWYNEO is for topical use only. TWYNEO is not for oral, ophthalmic, or intravaginal use. Apply a thin layer of TWYNEO to the affected areas once daily. ( 2 ) Avoid contact with eyes, lips, paranasal creases, and mucous membranes. ( 2 ) Wash hand after application. ( 2 ) Not for oral, ophthalmic, or intravaginal use. ( 2 )

Contraindications

4 CONTRAINDICATIONS TWYNEO is contraindicated in patients with a history of hypersensitivity reaction to benzoyl peroxide or any components of TWYNEO [see Warnings and Precautions (5.1) ] . History of serious hypersensitivity reaction to benzoyl peroxide or any component of TWYNEO. ( 4 )

Adverse Reactions

6 ADVERSE REACTIONS The most common adverse reactions (incidence ≥ 1%) are pain, dryness, exfoliation erythema, dermatitis, pruritus and irritation (all at the application site). ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Galderma Laboratories, L.P. at 1-866-735-4137 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical trials experience The following adverse reactions are discussed in greater detail elsewhere in the labeling: Hypersensitivity [see Warnings and Precautions (5.1 )] Skin Irritation [see Warnings and Precautions (5.2) ] Because clinical trials are conducted under widely varying conditions, adverse reaction rates are observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. In two multicenter, randomized, double-blind, vehicle-controlled trials (Trial 1 and 2), 832 subjects 9 years of age and older with facial acne vulgaris applied TWYNEO (N=555) or vehicle (N=277) daily for 12 weeks. The majority of subjects were White (73%) and female (59%). Approximately 33% were Hispanic/Latino, and 46% were younger than 18 years of age. Adverse react

Frequently Asked Questions

What is Twyneo used for?

Twyneo contains Benzoyl Peroxide and Tretinoin. It is a cream taken topical. Consult your doctor for specific uses.

Is Twyneo a controlled substance?

Twyneo is not classified as a controlled substance by the DEA.

What is the generic name for Twyneo?

The generic name for Twyneo is Benzoyl Peroxide and Tretinoin. There are no other listed brand versions of Benzoyl Peroxide and Tretinoin.

What is the NDC code for Twyneo 30 mg/g?

The NDC (National Drug Code) for Twyneo 30 mg/g is 51862-771, listed by Mayne Pharma Commercial LLC.

Product NDC

51862-771

Package NDC

51862-771-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)